Ftse Mib
33.683,16
1,39%
DAX
18.254,18
1,03%
S&P 500
5.473,17
-0,25%
NASDAQ
17.721,59
-0,79%
Bitcoin
65.043,73
0,13%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cingulate Inc (CINGW) Cingulate Inc (CINGW) Notizie

Cingulate Inc

CINGW
0,0103
0,00 (0,00%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 23:21:06
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Warrant Azionario
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/6/202423:00EDGAR2Form PRE 14A - Other preliminary proxy statements
18/6/202414:00EDGAR2Form 8-K - Current report
14/6/202401:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202401:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202401:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202401:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202401:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202401:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202423:00EDGAR2Form 8-K - Current report
08/6/202400:00EDGAR2Form SC 13D/A - General statement of acquisition of..
28/5/202423:54EDGAR2Form SC 13D/A - General statement of acquisition of..
28/5/202415:20EDGAR2Form 8-K - Current report
24/5/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
23/5/202423:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/5/202415:00GLOBEFDA Clears Cingulate to File for Marketing Approval of..
17/5/202423:01EDGAR2Form S-1 - General form for registration of securities under..
13/5/202414:00EDGAR2Form 8-K - Current report
08/5/202413:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202413:10EDGAR2Form 8-K - Current report
08/5/202413:00GLOBECingulate Reports First Quarter 2024 Financial Results and..
30/4/202411:45GLOBEPeter J. Werth, Successful Pharma Entrepreneur,..
16/4/202423:00GLOBECingulate to Participate in Planet MicroCap Showcase: Vegas..
01/4/202414:00GLOBECingulate Inc. Reports Fourth Quarter and Full Year 2023..
19/3/202421:45GLOBECingulate to Participate in Benzinga All Live Access Event
06/3/202412:45GLOBECingulate to Attend DCAT Week 2024 in New York City
13/2/202412:45GLOBECingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff..
06/2/202422:15GLOBECingulate Announces Closing of $7.5 Million Public Offering
02/2/202415:15GLOBECingulate Announces Pricing of $7.5 Million Public Offering
29/1/202414:00GLOBELongtime Cingulate Controller Jennifer Callahan Promoted to..
29/1/202412:45GLOBEWerth Family Investment Associates Converts Remaining $3.3M..
01/12/202315:00GLOBECingulate Receives Guidance from FDA on Path Forward for..
13/11/202322:15GLOBECingulate Inc. Reports Third Quarter 2023 Financial..
17/10/202320:22GLOBECingulate to Host CNS Key Opinion Leader Panel in New York..
21/9/202319:30GLOBECingulate Inc. to Present at the LD Micro Main Event XVI
13/9/202322:15GLOBECingulate Announces Closing of $4.0 Million Public Offering
11/9/202315:22GLOBECingulate Announces Pricing of $4.0 Million Public Offering
11/9/202312:00GLOBECingulate Announces Detailed Trial Results from Phase 3..
08/9/202322:31GLOBEWerth Family Investment Associates Converts $5.8 Million of..
05/9/202314:00GLOBECingulate Announces Presentation of Full Trial Results from..
14/8/202322:15GLOBECingulate Inc. Reports Second Quarter 2023 Financial..
11/7/202314:00GLOBECingulate Announces Positive Top-Line Results from Phase 3..
29/6/202314:00GLOBECingulate Successfully Manufactures Clinical Supply –..
Apertura: 0,0103 Min: 0,0103 Max: 0,0103
Chiusura: 0,0103

La tua Cronologia

NASDAQ
CINGW
Cingulate
BIT
I09206
Intesa Sanpaolo
BIT
F18381
Vontobel Financial Produ...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network